Julie Varkey , Kirsten Mehlig , Antal Bajor , Shilla Khalil , Mihai Oltean , Markus Gäbel , William Bennet , Jonas Varkey
{"title":"Low muscle mass in intestinal transplant recipients: Prevalence, outcomes, and longitudinal analysis of body composition","authors":"Julie Varkey , Kirsten Mehlig , Antal Bajor , Shilla Khalil , Mihai Oltean , Markus Gäbel , William Bennet , Jonas Varkey","doi":"10.1016/j.clnesp.2025.05.035","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Intestinal transplantation (ITX) is a life-saving treatment for patients with irreversible intestinal failure. While short-term survival has improved, long-term outcomes remain challenging, and the role of Low Muscle Mass (LMM) in influencing post-transplant outcomes is unclear. This study investigates the prevalence and impact of LMM on long-term survival in adults who underwent ITX, while also examining the longitudinal changes in body composition following transplantation.</div></div><div><h3>Methods</h3><div>This retrospective study included 26 adult patients who underwent ITX from February 2000 to August 2023. Body composition was assessed using Dual-Energy X-ray Absorptiometry (DEXA) scans, focusing on appendicular skeletal muscle mass index (ASMI) as an indicator of LMM. Longitudinal changes in ASMI, body fat percentage, body mass index (BMI), and bone mineral density (BMD) were analyzed using mixed linear regression models. Survival analysis was conducted using Kaplan–Meier curves and Cox proportional hazards regression.</div></div><div><h3>Results</h3><div>Pre-transplant LMM was prevalent in 58 % of patients. Patients with LMM were younger (34 years vs. 49 years, p = 0.001), with lower BMI (18.8 vs. 23.4, p = 0.003) and ASMI (5.1 vs. 6.8, p = 0.0003). Over up to 10 years of follow-up, average ASMI change was 0.02 kg/m<sup>2</sup>/year (−0.06, 0.10), showing positive time trends in patients younger than 40 years and negative trends in older patients (interaction p = 0.04). A similar age dependence was seen for BMD (interaction p = 0.01). ASMI, BMI, and fat percentage increased from pre-TX to the most recent follow-up, but these changes were not significantly different from zero. Additionally, 5-year mortality and overall survival rates did not significantly differ by pre-TX LMM status.</div></div><div><h3>Conclusion</h3><div>Pre-TX LMM is common in ITX patients but does not significantly impact long-term survival or body composition post-transplant. Thus, LMM alone may not be a contraindication for ITX, and muscle mass remained relatively stable over the follow-up period.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"68 ","pages":"Pages 410-416"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725003262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Intestinal transplantation (ITX) is a life-saving treatment for patients with irreversible intestinal failure. While short-term survival has improved, long-term outcomes remain challenging, and the role of Low Muscle Mass (LMM) in influencing post-transplant outcomes is unclear. This study investigates the prevalence and impact of LMM on long-term survival in adults who underwent ITX, while also examining the longitudinal changes in body composition following transplantation.
Methods
This retrospective study included 26 adult patients who underwent ITX from February 2000 to August 2023. Body composition was assessed using Dual-Energy X-ray Absorptiometry (DEXA) scans, focusing on appendicular skeletal muscle mass index (ASMI) as an indicator of LMM. Longitudinal changes in ASMI, body fat percentage, body mass index (BMI), and bone mineral density (BMD) were analyzed using mixed linear regression models. Survival analysis was conducted using Kaplan–Meier curves and Cox proportional hazards regression.
Results
Pre-transplant LMM was prevalent in 58 % of patients. Patients with LMM were younger (34 years vs. 49 years, p = 0.001), with lower BMI (18.8 vs. 23.4, p = 0.003) and ASMI (5.1 vs. 6.8, p = 0.0003). Over up to 10 years of follow-up, average ASMI change was 0.02 kg/m2/year (−0.06, 0.10), showing positive time trends in patients younger than 40 years and negative trends in older patients (interaction p = 0.04). A similar age dependence was seen for BMD (interaction p = 0.01). ASMI, BMI, and fat percentage increased from pre-TX to the most recent follow-up, but these changes were not significantly different from zero. Additionally, 5-year mortality and overall survival rates did not significantly differ by pre-TX LMM status.
Conclusion
Pre-TX LMM is common in ITX patients but does not significantly impact long-term survival or body composition post-transplant. Thus, LMM alone may not be a contraindication for ITX, and muscle mass remained relatively stable over the follow-up period.
期刊介绍:
Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.